ArticleHuman vaccines & immunotherapeutics2026
Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-β bifunctional fusion protein in recurrent cervical cancer.
Yucen Mao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.